The Lipidomics Market: By Sample Type (Blood Sample, Tissue Sample, Others) By lipid source (Human Source, Animal Source, Plant Source), By Application (Drug Discovery, Biomarker Discovery, Personalized Medicine, Diagnosis and Treatment, Others), By End user (Biopharmaceutical Companies, Agriculture Industries, Food and Beverage Industries, Academic Research Institutes) By Geography (Latin America, North America, Asia Pacific, the Middle East and Africa and Europe) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Global Lipidomics Market Report
Lipidomics is an emerging biomedical research discipline, which involves complex lipidome analysis. Lipidome is a quantitative and comprehensive description of a set of lipid species in an organism. Lipidomics involves system level quantitation and identification of several number of networks and pathways of cellular lipids and interaction with other proteins and moieties.
Market Dynamics: Lipidomics Market
Increase in need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in field of lipidomics and huge investments from the public and private sectors for R&D activities are anticipated to fuel the lipidomics market growth over the forecast period. Moreover, wide range of applications of lipidomics, increase in the prevalence of target diseases such as cancers, and increase in scope of clinical trials and toxicological studies are expected to boost lipidomics market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing are expected to hamper the growth of lipidomics services over the forecast period.
Market Scope: Lipidomics Market
The Lipidomics Market is classified on the basis of sample type, service type, lipid source, application, end user and regions.
Based on sample type, Lipidomics services market is segmented into the following
- Blood Sample
- Tissue Sample
- Others
Based on the lipid source, Lipidomics services market is segmented into the following
- Human Source
- Animal Source
- Plant Source
Based on the application, Metabolomics market is segmented into the following
- Drug Discovery
- Biomarker Discovery
- Personalized Medicine
- Diagnosis and treatment
- Others
Based on end user, Metabolomics Services market is segmented into the following
- Biopharmaceutical Companies
- Agriculture Industries
- Food and Beverage Industry
- Academic Research Institutes
Based on Region, Metabolomics Market is segmented as
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East and Africa
Regional Analysis: Lipidomics Market
Lipidomics services market is segmented as Latin America, Europe, Asia Pacific, North America, and The Middle East and Africa. North America estimated to account for significant revenue share in global services market owing to huge number of bio pharmaceutical companies focused on the R&D activities of lipidomics, rise in funds from the government organizations, and availability of professional researchers and well-established infrastructure. Europe is expected to expand at significant growth rate due to high adoption of novel technologies; researchers and governments concentrated on prevention of genetic disorders, and increase in target disease conditions. Moreover, increase in population and birth rate, rise in prevalence of diabetes and other targeted diseases, increase in R&D activities in China, Japan, and India, rise in demand for personalized medicine in Asia-Pacific region expected to create significant opportunities for Lipidomics market over the forecast period.
Competition Assessment: Lipidomics Market
Some of the players in Lipidomics services market are
- Zora Biosciences Oy (Finland)
- OWL Metabolomics (Spain)
- ProSciento (U.S.)
- Avanti Lipids Polar, Inc. (U.S.)
- The Metabolomics Innovation Centre (U.S.)
- VCU Massey Cancer Center (U.S.)
- Virginia Commonwealth University (U.S.)
- Lipotype GmbH (Germany)
- School of Medicine (Wayne State University) (U.S.)
- Metabolon, Inc. (U.S.)
- Waters Corporation (U.S.)
- Lipotype GmbH (Germany)
Notable Market Developments
- In September 2016, Lipotype GmbH launched its novel Lipotype shot gun skin lipidomics technology.
- In June 2015, SCIEX a lifescience analytical technologies company and Metabolon a lipidomics company entered into a multi-year collaboration, and they released The Lipidizer Platform, aan integrated solution for accurate next generation lipidomics.
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2013-2016) and forecast (2018-2024)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
